Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis

Silva, Debra, Rodríguez del Río, Pablo, Jong, Nicolette W., Khaleva, Ekaterina, Singh, Chris, Nowak-Wegrzyn, Anna, Muraro, Antonella, Begin, Philippe, Pajno, Giovanni, Fiocchi, Alessandro, Sanchez, Angel, Jones, Carla, Nilsson, Caroline, Bindslev-Jensen, Carsten, Wong, Gary, Sampson, Hugh, Beyer, Kirsten, Marchisotto, Mary-Jane, Fernandez Rivas, Montserrat, Meyer, Rosan, Lau, Susanne, Nurmatov, Ulugbek ORCID: https://orcid.org/0000-0002-9557-8635 and Roberts, Graham 2022. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis. Allergy 77 (6) , pp. 1852-1862. 10.1111/all.15211

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial. Download (1MB) | Preview

Abstract

Background There is substantial interest in immunotherapy and biologicals in IgE-mediated food allergy. Methods We searched six databases for randomized controlled trials about immunotherapy alone or with biologicals (to April 2021) or biological monotherapy (to September 2021) in food allergy confirmed by oral food challenge. We pooled the data using random-effects meta-analysis. Results We included 36 trials about immunotherapy with 2126 mainly child participants. Oral immunotherapy increased tolerance whilst on therapy for peanut (RR 9.9, 95% CI 4.5.–21.4, high certainty); cow's milk (RR 5.7, 1.9–16.7, moderate certainty) and hen's egg allergy (RR 8.9, 4.4–18, moderate certainty). The number needed to treat to increase tolerance to a single dose of 300 mg or 1000 mg peanut protein was 2. Oral immunotherapy did not increase adverse reactions (RR 1.1, 1.0–1.2, low certainty) or severe reactions in peanut allergy (RR 1,6, 0.7–3.5, low certainty), but may increase (mild) adverse reactions in cow's milk (RR 3.9, 2.1–7.5, low certainty) and hen's egg allergy (RR 7.0, 2.4–19.8, moderate certainty). Epicutaneous immunotherapy increased tolerance whilst on therapy for peanut (RR 2.6, 1.8–3.8, moderate certainty). Results were unclear for other allergies and administration routes. There were too few trials of biologicals alone (3) or with immunotherapy (1) to draw conclusions. Conclusions Oral immunotherapy improves tolerance whilst on therapy and is probably safe in peanut, cow's milk and hen's egg allergy. More research is needed about quality of life, cost and biologicals.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License
Publisher:	Wiley
ISSN:	0105-4538
Date of First Compliant Deposit:	9 August 2022
Date of Acceptance:	19 December 2021
Last Modified:	17 May 2023 21:12
URI:	https://orca.cardiff.ac.uk/id/eprint/151827

Citation Data

Cited 25 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item